Headlands Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.64M | Buy |
12,653
+9,259
| +273% | +$4.86M | 0.8% | 21 |
|
|
2025
Q1 | $2.15M | Sell |
3,394
-1,997
| -37% | -$1.27M | 0.25% | 104 |
|
|
2024
Q4 | $3.84M | Sell |
5,391
-201
| -4% | -$143K | 0.39% | 58 |
|
|
2024
Q3 | $5.88M | Buy |
+5,592
| New | +$5.88M | 0.68% | 28 |
|
|
2024
Q2 | – | Sell |
-845
| Closed | -$813K | – | 1531 |
|
|
2024
Q1 | $813K | Sell |
845
-398
| -32% | -$383K | 0.2% | 130 |
|
|
2023
Q4 | $1.09M | Buy |
1,243
+1,238
| +24,760% | +$1.09M | 0.33% | 71 |
|
|
2023
Q3 | $4.12K | Buy |
+5
| New | +$4.12K | ﹤0.01% | 778 |
|
|
2023
Q1 | – | Sell |
-3,235
| Closed | -$2.33M | – | 716 |
|
|
2022
Q4 | $2.33M | Buy |
+3,235
| New | +$2.33M | 1.85% | 9 |
|